www.chinooktx.com Open in urlscan Pro
69.63.141.106  Public Scan

Form analysis
0 forms found in the DOM

Text Content

We use cookies, which are small text files, to improve your experience on our
website and to show you personalized content. View our Privacy Policy. Accept
All


> Changing the Course of Kidney Care™

> Chinook is now a Novartis Company!

On August 11, 2023, Novartis completed its acquisition of Chinook Therapeutics.

View Press Release | Visit Novartis Website

> Chinook is a clinical-stage biopharmaceutical company discovering, developing
> and commercializing precision medicines for rare, severe chronic
> kidney diseases.

Read More


THE LATEST FROM CHINOOK
 


PRESS RELEASES

Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 BEYOND
Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy
July 28, 2023

Chinook Therapeutics Presents Data from CHK-336 Phase 1 Trial in Healthy
Volunteers and New Insights into the Role of Failed Repair in Chronic Kidney
Disease at the 60th European Renal Association (ERA) Congress
June 17, 2023


PRESS RELEASES

Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 BEYOND
Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy
July 28, 2023

Chinook Therapeutics Presents Data from CHK-336 Phase 1 Trial in Healthy
Volunteers and New Insights into the Role of Failed Repair in Chronic Kidney
Disease at the 60th European Renal Association (ERA) Congress
June 17, 2023


EVENTS

Details on upcoming events are not yet available.

Bank of America Securities Healthcare Conference 2023

Wednesday, May 10TH, 2023 at 2:20 PM Eastern
Click here for webcast

 * About Us
    * Overview
    * Purpose & Values

 * Pipeline
    * Pipeline
    * IgA Nephropathy
    * Atrasentan
    * Zigakibart (BION-1301)
    * CHK-336
    * Research and Discovery
    * Scientific Publications

 * Patients
    * Clinical Trials
    * Patient Resources
    * Advocacy Partners

 * Investors
    * Press Releases
    * Financials & Filings

 * Join Us
    * Join Our Team
    * Spotlights
    * Job Opportunities
    * Life at Chinook

 * Contact

 * Home
 * About Us
    * Overview
    * Purpose & Values

 * Pipeline
    * Pipeline
    * IgA Nephropathy
    * Atrasentan
    * Zigakibart (BION-1301)
    * CHK-336
    * Research and Discovery
    * Scientific Publications

 * Patients
    * Clinical Trials
    * Patient Resources
    * Advocacy Partners

 * Investors
    * Press Releases
    * Financials & Filings

 * Join Us
    * Join Our Team
    * Spotlights
    * Job Opportunities
    * Life at Chinook

 * Contact

 * Terms of Use
 * Privacy Policy

© 2024 Chinook Therapeutics Inc. All rights reserved. CHINOOK, CHINOOK
THERAPEUTICS and the CHINOOK THERAPEUTICS Logo are trademarks of Chinook
Therapeutics, Inc.
 * Terms of Use
 * Privacy Policy

Website Design: Hane Chow, Inc.

> Chinook is now a Novartis Company!

On August 11, 2023, Novartis completed its acquisition of Chinook Therapeutics.

View Press Release | Visit Novartis Website